Save The Date | February 3-4, 2023 | Friday-Saturday
The Biltmore Hotel Miami Coral Gables, Miami, Florida
Given the increasing discovery of oncogenic-driven tumors, targeted treatments with novel agents have transformed the outcomes in these patients. Clinical decision making and management therefore have become more complex. There is a need to provide an opportunity for medical oncologists, radiation oncologists, pathologists, allied health professionals, oncology nurses and pharmacists to engage in thoughtful discussions with experts in these fields. In addition, there is emerging data about the biology of these malignancies impacting optimal management of patients with these disorders.
This one-and-a-half-day symposium has been designed to provide an overview and opportunity to learn about the most recent advances in the treatment of solid tumors, including lung cancer, breast cancer, gastrointestinal tumors, genitourinary tumors, head and neck tumors, melanoma, sarcoma, brain tumors by novel targeted agents and treatment combinations. Updates on evolving molecular-based system therapies will be profiled and discussed.
MORE INFORMATION AND REGISTER >>